Regulation and biosynthesis of carbapenem antibiotics in bacteria

Nature Reviews Microbiology

Volumn 3, Issue 4, 2005, Pages 295-306

  Coulthurst, Sarah J ^a   Barnard, Anne M L ^a   Salmond, George P C ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ENZYME; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE; CARBAPENEM DERIVATIVE; CEPHALOSPORIN DERIVATIVE; CEPHAMYCIN DERIVATIVE; DNA BINDING PROTEIN; EPIMERASE; ERTAPENEM; IMIPENEM; ISOPENICILLIN N SYNTHETASE; MEROPENEM; MONOBACTAM DERIVATIVE; PENICILLIN DERIVATIVE; PEPTIDOGLYCAN; REGULATOR PROTEIN; SYNTHETASE; THIENAMYCIN;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; BACTERIAL CELL WALL; BACTERIAL GENETICS; BIOCHEMISTRY; DRUG ACTIVITY; DRUG ISOLATION; DRUG RESEARCH; DRUG STRUCTURE; DRUG SYNTHESIS; ENZYME ANALYSIS; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; NONHUMAN; PECTOBACTERIUM CAROTOVORUM; PHOTORHABDUS LUMINESCENS; PRIORITY JOURNAL; PROTEIN SYNTHESIS INHIBITION; REVIEW; SERRATIA; STREPTOMYCES; STREPTOMYCES CATTLEYA;

ANTI-BACTERIAL AGENTS; BACTERIA; BACTERIAL PROTEINS; CARBAPENEMS; DRUG RESISTANCE, BACTERIAL; ENZYMES; GENES, BACTERIAL; TRANSCRIPTION FACTORS;

BACTERIA (MICROORGANISMS); CATTLEYA; ERWINIA; NEGIBACTERIA; PECTOBACTERIUM; PECTOBACTERIUM CAROTOVORUM SUBSP. CAROTOVORUM; PHOTORHABDUS LUMINESCENS; POSIBACTERIA; SERRATIA; SERRATIA SP.; STREPTOMYCES; STREPTOMYCES CATTLEYA;

EID: 15944426814     PISSN: 17401526     EISSN: None     Source Type: Journal    
DOI: 10.1038/nrmicro1128     Document Type: Review

References (59)

1. Elander, R. P. Industrial production of β-lactam antibiotics. Appl. Microbiol. Biotechnol. 61, 385-392 (2003).
2. Fleming, A. On the antibacterial action of cultures of a Penicillium, with special reference to their use in the isolation of B. influenzae. Br. J. Exp. Pathol. 10, 226-236 (1929).
3. Tipper, D. J. & Strominger, J. L. Mechanism of action of penicillins: a proposal based on their structural similarity to acyl-D-alanyl-D-alanine. Proc. Natl Acad. Sci. USA 54, 1133-1141 (1965).
4. Bradley, J. S. et al. Carbapenems in clinical practice: a guide to their use in serious infection. Int. J. Antimicrob. Agents 11, 93-100 (1999).
5. Kahan, J. S. et al. Thienamycin, a new β-lactam antibiotic. I. Discovery, taxonomy, isolation and physical properties. J. Antibiot. (Tokyo) 32, 1-12 (1979).
6. Nunez, L. E., Mendez, C., Brana, A. F., Blanco, G. & Salas, J. A. The biosynthetic gene cluster for the β-lactam carbapenem thienamycin in Streptomyces cattleya. Chem. Biol. 10, 301-311 (2003).
7. Parker, W. L. et al. SQ 27,860, a simple carbapenem produced by species of Serratia and Erwinia. J. Antibiot. (Tokyo) 35, 653-660 (1982).
8. Derzelle, S., Duchaud, E., Kunst, F., Danchin, A. & Bertin, P. Identification, characterization, and regulation of a cluster of genes involved in carbapenem biosynthesis in Photorhabdus luminescens. Appl. Environ. Microbiol. 68, 3780-3789 (2002).
9. Livermore, D. M. β-Lactamase-mediated resistance and opportunities for its control. J. Antimicrob. Chemother. 41 (Suppl. D), 25-41 (1998).
10. Hawkey, P. M. The origins and molecular basis of antibiotic resistance. BMJ 317, 657-660 (1998).
11. Livermore, D. M. Acquired carbapenemases. J. Antimicrob. Chemother. 39, 673-676 (1997).
12. Nordmann, P. & Poirel, L. Emerging carbapenemases in Gram-negative aerobes. Clin. Microbiol. Infect. 8, 321-331 (2002).
13. Rasmussen, B. A. & Bush, K. Carbapenem-hydrolyzing β-lactamases. Antimicrob. Agents Chemother. 41, 223-232 (1997).
14. Edwards, J. R. & Betts, M. J. Carbapenems: the pinnacle of the β-lactam antibiotics or room for improvement? J. Antimicrob. Chemother. 45, 1-4 (2000).
15. Livermore, D. M., Sefton, A. M. & Scott, G. M. Properties and potential of ertapenem. J. Antimicrob. Chemother. 52, 331-344 (2003).
16. Shah, P. M. & Isaacs, R. D. Ertapenem, the first of a new group of carbapenems. J. Antimicrob. Chemother. 52, 538-542 (2003).
17. Miller, T. W. Crystalline N-formimidoylthienamycin. US Patent 4260543 (1981).
18. McGowan, S. J., Bycroft, B. W. & Salmond, G. P. Bacterial production of carbapenems and clavams: evolution of β-lactam antibiotic pathways. Trends Microbiol. 6, 203-208 (1998).
19. Bycroft, B. W., Maslen, C., Box, S. J., Brown, A. & Tyler, J. W. The biosynthetic implications of acetate and glutamate incorporation into (3R,5R)-carbapenam-3-carboxylic acid and (5R)-carbapen-2-em-3-carboxylic acid by Serratia sp. J. Antibiot. (Tokyo) 41, 1231-1242 (1988).
20. Whitehead, N. A., Barnard, A. M., Slater, H., Simpson, N. J. & Salmond, G. P. Quorum-sensing in Gram-negative bacteria. FEMS Microbiol. Rev. 25, 365-404 (2001).
21. McGowan, S. J. et al. Analysis of bacterial carbapenem antibiotic production genes reveals a novel β-lactam biosynthesis pathway. Mol. Microbiol. 22, 415-426 (1996).
22. Holder, M. T. et al. Cryptic carbapenem antibiotic production genes are widespread in Erwinia carotovora: facile trans activation by the carR transcriptional regulator. Microbiology 144, 1495-1508 (1998).
23. Bell, K. S. et al. Genome sequence of the enterobacterial phytopathogen Erwinia carotovora subsp. atroseptica and characterization of virulence factors. Proc. Natl Acad. Sci. USA 101, 11105-11110 (2004).
24. McGowan, S. et al. Carbapenem antibiotic biosynthesis in Erwinia carotovora is regulated by physiological and genetic factors modulating the quorum sensing-dependent control pathway. Mol. Microbiol. 55, 526-545 (2005).
25. Welch, M. et al. N-acyl homoserine lactone binding to the CarR receptor determines quorum-sensing specificity in Erwinia. EMBO J. 19, 631-641 (2000).
26. Whitehead, N. A. et al. The regulation of virulence in phytopathogenic Erwinia species: quorum sensing, antibiotics and ecological considerations. Antonie Van Leeuwenhoek 81, 223-231 (2002).
27. Rivet, M. M. Investigation into the regulation of exoenzyme production in Erwinia carotovora subspecies carotovora. Thesis, Univ. Warwick, Coventry, UK (1998).
28. Cox, A. R. et al. A pheromone-independent CarR protein controls carbapenem antibiotic synthesis in the opportunistic human pathogen Serratia marcescens. Microbiology 144, 201-209 (1998).
29. Thomson, N. R., Crow, M. A., McGowan, S. J., Cox, A. & Salmond, G. P. Biosynthesis of carbapenem antibiotic and prodigiosin pigment in Serratia is under quorum sensing control. Mol. Microbiol. 36, 539-556 (2000).
30. Slater, H., Crow, M., Everson, L. & Salmond, G. P. Phosphate availability regulates biosynthesis of two antibiotics, prodigiosin and carbapenem, in Serratia via both quorum-sensing-dependent and-independent pathways. Mol. Microbiol. 47, 303-320 (2003).
31. Coulthurst, S. J., Whitehead, N. A., Welch, M. & Salmond, G. P. Can boron get bacteria talking? Trends Biochem. Sci. 27, 217-219 (2002).
32. Xavier, K. B. & Bassler, B. L. LuxS quorum sensing: more than just a numbers game. Curr. Opin. Microbiol. 6, 191-197 (2003).
33. Coulthurst, S. J., Kurz, C. L. & Salmond, G. P. luxS mutants of Serratia defective in autoinducer-2-dependent 'quorum sensing' show strain-dependent impacts on virulence and production of carbapenem and prodigiosin. Microbiology 150, 1901-1910 (2004).
34. Thomson, N. R. et al. The Rap and Hor proteins of Erwinia, Serratia and Yersinia: a novel subgroup in a growing superfamily of proteins regulating diverse physiological processes in bacterial pathogens. Mol. Microbiol. 26, 531-544 (1997).
35. McGowan, S. et al. Carbapenem antibiotic production in Erwinia carotovora is regulated by CarR, a homologue of the LuxR transcriptional activator. Microbiology 141, 541-550 (1995).
36. McGowan, S. J. et al. Analysis of the carbapenem gene cluster of Erwinia carotovora: definition of the antibiotic biosynthetic genes and evidence for a novel β-lactam resistance mechanism. Mol. Microbiol. 26, 545-556 (1997).
37. Li, R., Stapon, A., Blanchfield, J. T. & Townsend, C. A. Three unusual reactions mediate carbapenem and carbapenam biosynthesis. J. Am. Chem. Soc. 122, 9296-9297 (2000).
38. Demain, A. L. & Elander, R. P. The β-lactam antibiotics: past, present, and future. Antonie Van Leeuwenhoek 75, 5-19 (1999).
39. Bycroft, B., Chhabra, S. R., Kellam, B. & Smith, P. Convenient syntheses of (3S,5S)-carbapenam-3-carboxylates and their biosynthetic relevance. Tetrahedron Lett. 44, 973-976 (2003).
40. Stapon, A., Li, R. & Townsend, C. A. Carbapenem biosynthesis: confirmation of stereochemical assignments and the role of CarC in the ring stereoinversion process from L-proline. J. Am. Chem. Soc. 125, 8486-8493 (2003).
41. Sleeman, M. C. & Schofield, C. J. Carboxymethylproline synthase (CarB), an unusual carbon-carbon bond-forming enzyme of the crotonase superfamily involved in carbapenem biosynthesis. J. Biol. Chem. 279, 6730-6736 (2004).
42. Gerratana, B., Stapon, A. & Townsend, C. A. Inhibition and alternate substrate studies on the mechanism of carbapenam synthetase from Erwinia carotovora. Biochemistry 42, 7836-7847 (2003).
43. Miller, M. T., Gerratana, B., Stapon, A., Townsend, C. A. & Rosenzweig, A. C. Crystal structure of carbapenam synthetase (CarA). J. Biol. Chem. 278, 40996-41002 (2003).
44. Miller, M. T., Bachmann, B. O., Townsend, C. A. & Rosenzweig, A. C. The catalytic cycle of β-lactam synthetase observed by X-ray crystallographic snapshots. Proc. Natl Acad. Sci. USA 99, 14752-14757 (2002).
45. Clifton, I. J. et al. Crystal structure of carbapenem synthase (CarC). J. Biol. Chem. 278, 20843-20850 (2003).
46. Townsend, C. A. New reactions in clavulanic acid biosynthesis. Curr. Opin. Chem. Biol. 6, 583-589 (2002).
47. Stapon, A., Li, R. & Townsend, C. A. Synthesis of (3S 5R)-carbapenam-3-carboxylic acid and its role in carbapenem biosynthesis and the stereoinversion problem. J. Am. Chem. Soc. 125, 15746-15747 (2003).
48. Topf, M. et al. The unusual bifunctional catalysis of epimerization and desaturation by carbapenem synthase. J. Am. Chem. Soc. 126, 9932-9933 (2004).
49. Sleeman, M. C. et al. Biosynthesis of carbapenem antibiotics: new carbapenam substrates for carbapenem synthase (CarC). Chembiochem. 5, 879-882 (2004).
50. Miller, M. T., Bachmann, B. O., Townsend, C. A. & Rosenzweig, A. C. Structure of β-lactam synthetase reveals how to synthesize antibiotics instead of asparagine. Nature Struct. Biol. 8, 684-689 (2001).
51. Maes, T. et al. The att locus of Rhodococcus fascians strain D188 is essential for full virulence on tobacco through the production of an autoregulatory compound. Mol. Microbiol. 42, 13-28 (2001).
52. Williamson, J. M. et al. Biosynthesis of the β-lactam antibiotic, thienamycin, by Streptomyces cattleya. J. Biol. Chem. 260, 4637-4647 (1985).
53. Abraham, E. P. & Chain, E. An enzyme from bacteria able to destroy penicillin. Nature 146, 837 (1940).
54. Abraham, E. P. in Antibiotics Containing the β-Lactam Structure I. (eds Demain, E. P. & Solomon, N. A.) 1-14 (Springer, Berlin, Heidelberg, 1983).
55. Aoki, H. et al. Nocardicin A, a new monocyclic β-lactam antibiotic. I. Discovery, isolation and characterization. J. Antibiot. 29, 492-500 (1976).
56. Reading, C. & Cole, M. Clavulanic acid: a β-lactamase-inhibiting β-lactam from Streptomyces clavuligerus. Antimicrob. Agents Chemother. 11, 852-857 (1977).
57. Holden, M. T. G. Molecular Genetic Analysis of Cryptic Antibiotic Genes in Erwinia carotovora subspecies carotovora. Thesis, Univ. Warwick, Coventry, UK (1996).
58. Martin, J. F. New aspects of genes and enzymes for β-lactam antibiotic biosynthesis. Appl. Microbiol. Biotechnol. 50, 1-15 (1998).
59. Gunsior, M. et al. The biosynthetic gene cluster for a monocyclic β-lactam antibiotic, nocardicin A. Chem. Biol. 11 927-938 (2004).